Ellansé M

Ellansé M, developed in 2009 and acquired by Sinclair Pharma in 2014, was designed to meet the needs of aesthetic medicine. The CE-certified ELLANSÉ range of bio-fillers offers a customizable shelf life of 1-4 years with options like ELLANSÉ S, M, L, and E.

Featuring unique STATTM technology, Ellansé allows controlled, gradual product breakdown tailored to individual patient needs. The polymer chains are lengthened to provide the desired longevity and efficacy, while its smooth texture ensures easy injection, offering both immediate and long-term benefits. The microparticles’ smooth surface and round shape ensure excellent biocompatibility.

Ellansé M is a soft, fully resorbable polymer based on polycaprolactone (PCL), which has been safely used in medical applications for decades. In this formulation, PCL microparticles stimulate collagen production, creating a long-lasting tissue scaffold that metabolizes naturally. Ideal for contouring, wrinkle reduction, and volume enhancement, Ellansé M is an excellent choice for aesthetic treatments.